TAYSIDE LASER CLINIC LIMITED
Opportunity 78/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Average employees | 0 | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (36 events)Click to expand
- 2025-09-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-09-12📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-09-11📄appoint-person-director-company-with-name-dateofficers · AP01
- 2024-09-11📄termination-director-company-with-name-termination-dateofficers · TM01
- 2024-08-26➕MCMULLAN, Alexandra Claire appointeddirector
- 2024-08-26➖MOSELEY, Harry resigneddirector
- 2023-07-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-08-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-07-20📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2021-08-25➖MOSELEY, Harry, Professor resignedsecretary
- 2021-03-31📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2020-12-29📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2020-12-28📄withdrawal-of-a-person-with-significant-control-statementpersons-with-significant-control · PSC09
- 2020-07-21📄accounts-amended-with-made-up-dateaccounts · AAMD
- 2020-06-15📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2019-03-07📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2018-05-03📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2017-03-16📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2016-10-27📄appoint-person-director-company-with-name-dateofficers · AP01
- 2016-10-06➕EADIE, Ewan, Dr appointeddirector
- 2016-10-06➖GARDNER, June resigneddirector
- 2015-05-11➕GARDNER, June appointeddirector
- 2015-05-11➖WOODS, Julie Ann resigneddirector
- 2013-12-19➖FERGUSON, James, Dr resignedsecretary
- 2013-12-12➕IBBOTSON, Sally Helen, Professor appointeddirector
- 2013-12-12➕MOSELEY, Harry, Professor appointedsecretary
- 2013-12-12➖FERGUSON, James, Dr resigneddirector
- 2006-09-15➕FERGUSON, James, Dr appointedsecretary
- 2006-09-15➖THORNTONS LAW LLP resignedcorporate-secretary
- 2006-09-15➕FERGUSON, James, Dr appointeddirector
- 2006-09-15➖HUTCHESON, Iain Henderson resigneddirector
- 2006-09-15➕MOSELEY, Harry appointeddirector
- 2006-09-15➕WOODS, Julie Ann appointeddirector
- 2006-08-29🏢Company incorporatedAs TAYSIDE LASER CLINIC LIMITED
- 2006-08-29➕THORNTONS LAW LLP appointedcorporate-secretary
- 2006-08-29➕HUTCHESON, Iain Henderson appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
- secondary12+ year tenure: Director in role 12 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanGroup structure
Laser Research & Therapy Fund is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Laser Research & Therapy Fund Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control · trust interest | 28/12/2020 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · DD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| OUTRUN THERAPEUTICS LIMITED→ SC648164 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| RULLY CARE LTD→ SC788887 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| SCOTSAFE TRANSPORT LTD→ SC852248 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| SOLUXE AESTHETICS LTD→ SC726026 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| TAY WELLBEING LIMITED→ SC808240 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| TAYSIDE HEALTHCARE ARTS TRUST→ SC307393 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| TEN BIO LIMITED→ SC642032 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| THE ADAM CENTRE→ SC252797 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| THE GYNAE-ONCOLOGY CLINIC LTD→ SC767307 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| THE PSYCHOTHERAPY COLLECTIVE LTD→ SC822256 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| TISSUE SOLUTIONS LIMITED→ SC331666 · est 2007 · no financials extracted | — | — | — | — | 18y | — | — |
| TJGIR LTD→ SC785587 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 8 resigned)
Click a director name to see their full track record across all companies.